Adactar, Rachel .
HRN: 03-49-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
AMPICILLIN 1GM (VIAL)
05/09/2025
05/11/2025
IVT
2g
Q6
PROM
Waiting Final Action
05/10/2025
CO-AMOXICLAV 625MG (TAB)
05/10/2025
05/17/2025
PO
625 Mg
BID
Thickly MSAF
Waiting Final Action